Antidote

Document Sample
Antidote Powered By Docstoc
					NEWS




                          Antidote          
				
DOCUMENT INFO
Description: Derived from the saliva of ticks, and working by a totally different mechanism than common blood thinner warfarin (Coumadin), studies have been ongoing on two drugs, dabigatran (Pradaxa), a direct thrombin (factor X) inhibitor which was approved by the FDA last month for blood thinning stroke patients with atrial fibrillation, and rivaroxaban (Xarelto), a factor Xa inhibitor which seems to be on the verge of approval. Both of these new drugs are patient friendly, not requiring blood tests or a special diet.
BUY THIS DOCUMENT NOW PRICE: $6.95 100% MONEY BACK GUARANTEED
PARTNER ProQuest LLC
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning.